PLYMOUTH, Minn., June 11 /CNW/ -- ev3 Inc. (Nasdaq: EVVV) today announced
that Pat Spangler, senior vice president and chief financial officer, is
scheduled to present at the Jefferies 2nd Annual Healthcare Conference in New
York City on Wednesday, June 25, 2008 at 11:45 a.m. ET (10:45 a.m. CT and 8:45
To access the webcast, go to the investors' section of the ev3 Web site
at www.ev3.net and click on the Webcast icon. The Webcast will be available
for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to improving the lives
of patients with vascular disease through the development of innovative
endovascular therapies. ev3's products are used by endovascular specialists
to treat a wide range of peripheral vascular and neurovascular diseases and
disorders. The company offers a comprehensive portfolio of treatment options,
including the primary interventional technologies used today -- peripheral
angioplasty balloons, stents, plaque excision systems, embolic protection
devices, liquid embolics, embolization coils, thrombectomy catheters and
occlusion balloons. More information about the company and its products can
be found at www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S.
and other countries.
For further information:
For further information: Julie Tracy, Sr. Vice President, Chief
Communications Officer of ev3 Inc., +1-949-680-1375, email@example.com Web Site: